These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 39136995)

  • 41. ATPR induces acute promyelocytic leukemia cells differentiation and cycle arrest via the lncRNA CONCR/DDX11/PML-RARα signaling axis.
    Liu S; Zhan W; He X; Hao M; Shen W; Zhang X; Wang M; Li Z; Hou R; Ou Z; Feng Y; Chen F
    Gene; 2024 Jul; 917():148443. PubMed ID: 38582263
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PML/RARalpha targets promoter regions containing PU.1 consensus and RARE half sites in acute promyelocytic leukemia.
    Wang K; Wang P; Shi J; Zhu X; He M; Jia X; Yang X; Qiu F; Jin W; Qian M; Fang H; Mi J; Yang X; Xiao H; Minden M; Du Y; Chen Z; Zhang J
    Cancer Cell; 2010 Feb; 17(2):186-97. PubMed ID: 20159610
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
    Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo analysis of the role of aberrant histone deacetylase recruitment and RAR alpha blockade in the pathogenesis of acute promyelocytic leukemia.
    Matsushita H; Scaglioni PP; Bhaumik M; Rego EM; Cai LF; Majid SM; Miyachi H; Kakizuka A; Miller WH; Pandolfi PP
    J Exp Med; 2006 Apr; 203(4):821-8. PubMed ID: 16549595
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cell death induction by the acute promyelocytic leukemia-specific PML/RARalpha fusion protein.
    Ferrucci PF; Grignani F; Pearson M; Fagioli M; Nicoletti I; Pelicci PG
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10901-6. PubMed ID: 9380732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PML-RARα and its phosphorylation regulate pml oligomerization and HIPK2 stability.
    Shima Y; Honma Y; Kitabayashi I
    Cancer Res; 2013 Jul; 73(14):4278-88. PubMed ID: 23722549
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Annexin A2-S100A10 heterotetramer is upregulated by PML/RARα fusion protein and promotes plasminogen-dependent fibrinolysis and matrix invasion in acute promyelocytic leukemia.
    Huang D; Yang Y; Sun J; Dong X; Wang J; Liu H; Lu C; Chen X; Shao J; Yan J
    Front Med; 2017 Sep; 11(3):410-422. PubMed ID: 28687976
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient.
    Koken MH; Daniel MT; Gianni M; Zelent A; Licht J; Buzyn A; Minard P; Degos L; Varet B; de Thé H
    Oncogene; 1999 Jan; 18(4):1113-8. PubMed ID: 10023688
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
    Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL
    Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166
    [TBL] [Abstract][Full Text] [Related]  

  • 50. C/EBPα is indispensable for PML/RARα-mediated suppression of long non-coding RNA NEAT1 in acute promyelocytic leukemia cells.
    Tang D; Hu P; Zhu D; Luo Y; Chen M; Zhang G; Wang Y
    Aging (Albany NY); 2021 Apr; 13(9):13179-13194. PubMed ID: 33901013
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Transcriptional regulation of BHLHB2 induced by PML-RARα].
    Jia XH; Yang WT; Zhu XH; Yang XW; Zhang J; Wang KK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):1005-9. PubMed ID: 21867633
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
    He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP
    Nat Genet; 1998 Feb; 18(2):126-35. PubMed ID: 9462740
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PML-RARα interferes with erythropoiesis by repressing LMO2 in acute promyelocytic leukaemia.
    Yang X; Tan Y; Wang P; Zhang H; Zhao M; Zhao X; Wang K
    J Cell Mol Med; 2018 Dec; 22(12):6275-6284. PubMed ID: 30320491
    [TBL] [Abstract][Full Text] [Related]  

  • 54. UBE1L represses PML/RAR{alpha} by targeting the PML domain for ISG15ylation.
    Shah SJ; Blumen S; Pitha-Rowe I; Kitareewan S; Freemantle SJ; Feng Q; Dmitrovsky E
    Mol Cancer Ther; 2008 Apr; 7(4):905-14. PubMed ID: 18413804
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Involvement of PML proteins in treatment of acute promyelocytic leukemia with arsenic trioxide].
    Hao R; Su L; Shao Y; Bu N; Ma L; Naranmandura H
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 May; 47(5):541-551. PubMed ID: 30693698
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of PML and PML-RARalpha in Mad-mediated transcriptional repression.
    Khan MM; Nomura T; Kim H; Kaul SC; Wadhwa R; Shinagawa T; Ichikawa-Iwata E; Zhong S; Pandolfi PP; Ishii S
    Mol Cell; 2001 Jun; 7(6):1233-43. PubMed ID: 11430826
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HIF factors cooperate with PML-RARα to promote acute promyelocytic leukemia progression and relapse.
    Coltella N; Percio S; Valsecchi R; Cuttano R; Guarnerio J; Ponzoni M; Pandolfi PP; Melillo G; Pattini L; Bernardi R
    EMBO Mol Med; 2014 May; 6(5):640-50. PubMed ID: 24711541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia.
    Grimwade D; Gorman P; Duprez E; Howe K; Langabeer S; Oliver F; Walker H; Culligan D; Waters J; Pomfret M; Goldstone A; Burnett A; Freemont P; Sheer D; Solomon E
    Blood; 1997 Dec; 90(12):4876-85. PubMed ID: 9389704
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Two critical hits for promyelocytic leukemia.
    He LZ; Bhaumik M; Tribioli C; Rego EM; Ivins S; Zelent A; Pandolfi PP
    Mol Cell; 2000 Nov; 6(5):1131-41. PubMed ID: 11106752
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of arsenic on the topology and solubility of promyelocytic leukemia (PML)-nuclear bodies.
    Hirano S; Udagawa O
    PLoS One; 2022; 17(5):e0268835. PubMed ID: 35594310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.